NEW HOPE DRUG AND ALCOHOL TREATMENT (EIN 203517540) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2005

Legal Domicile

Principal Officer

WILLIAM AKINWUMI

Phone

3237502850

Tax Period

2025-01-01 to 2025-12-31

NEW HOPE DRUG AND ALCOHOL TREATMENT, founded in 2005, is a community nonprofit in the Mental Health sector that reported $2.4M in total revenue in fiscal year 2025. Revenue surged 31% from the prior year, signaling strong growth momentum. The organization ran a surplus of $676K, a strong 28% operating margin.

Mission

provide support, treatment, education to the drug and alcohol abusers so that they can leave a productive life and detour them from the life of alcohol and drug dependence.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2025)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $2,405,591

Investment Income $13,805

Other Revenue $0

TOTAL REVENUE $2,419,396

Expense Breakdown

Grants Paid $0

Salaries & Benefits $1,219,794

Fundraising Expenses $0

Program Expenses $1,743,217

Other Expenses $523,423

TOTAL EXPENSES $1,743,217

Year-over-Year Comparison

	2025	2024	Change
Revenue	$2,419,396	$1,844,435	+0.3%
Expenses	$1,743,217	$1,378,380	+0.3%
Net Income	$676,179	$466,055	+0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM AKINWUMI	EXECUTIVE DIRECTOR	60.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$2,419,396	$1,743,217	$1,686,383	$676,179
2024	$1,844,435	$1,378,380	$1,010,204	$466,055
2023	$1,300,823	$1,096,146	$544,149	$204,677
2022	$1,054,082	$944,408	$339,472	$109,674
2021	$946,899	$817,752	$229,798	$129,147
2020	$753,651	$723,842	$100,651	$29,809
2019	$582,512	$538,882	$70,842	$43,630
2018	$412,877	$400,842	$27,212	$12,035

NEW HOPE DRUG AND ALCOHOL TREATMENT